Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03443206 · ClinicalTrials.gov registry record · NA

Loves Company: Combatting Emotional Disturbance in the Digital Age

A NA study of Adolescent - Emotional Problem, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
212
Enrollment target
1
Study location

NCT03443206: Completed NA study of Adolescent - Emotional Problem, sponsored by Northwell Health.

NCT03443206 is a NA study of Adolescent - Emotional Problem that has completed, run by Northwell Health. The registered enrollment target is 212 participants, roughly in line with the 214-participant average among 4 other Adolescent - Emotional Problem trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03443206, a NA study of Adolescent - Emotional Problem, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine whether a community-based website that is intended to provide support for adolescents experiencing psychological distress can improve members' mental health outcomes. The investigators want to understand if a digital platform can help young people who are suffering and may be unlikely to access more traditional forms of mental health services.

Primary Outcome

frequency of suicidal thoughts and behaviors

Interventions

  • OTHER anonymous social support
  • OTHER psychoeducation
  • OTHER online resources

Study Locations (1)

New York

  • Northwell Health - Glen Oaks

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2020-06-20
Est. Completion 2021-07-31
Phase NA
Northwell Health

370 total trials

What the finished NCT03443206 record still lists

NCT03443206 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 214-participant average among 4 other Adolescent - Emotional Problem trials with a reported enrollment target.

The record links to 1 condition, with Adolescent - Emotional Problem appearing as the primary indexed condition, and to 3 interventions - of which anonymous social support is the first listed.

NCT03443206 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03443206 about?

NCT03443206 is a clinical study titled "Loves Company: Combatting Emotional Disturbance in the Digital Age". The goal of this study is to determine whether a community-based website that is intended to provide support for adolescents experiencing psychological distress can improve members' mental health outcomes. The investigators want to understand if a digital platform can help young people who are suffe...

What is the current status of trial NCT03443206?

This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2020-06-20. Estimated completion is 2021-07-31.

What conditions does trial NCT03443206 study?

This clinical trial studies the following conditions: Adolescent - Emotional Problem.

What interventions are being tested in trial NCT03443206?

The interventions under investigation include: anonymous social support (OTHER), psychoeducation (OTHER), online resources (OTHER).

Who is sponsoring clinical trial NCT03443206?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03443206 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent - Emotional Problem

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03443206, the US trial registry maintained by the National Library of Medicine. NCT03443206 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.